SOURCE: Senomyx, Inc.

September 10, 2007 08:00 ET

Senomyx to Give Corporate Presentation at the Citigroup Healthy Lifestyles Seminar 2007

SAN DIEGO, CA--(Marketwire - September 10, 2007) - Senomyx, Inc. (NASDAQ: SNMX), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the packaged food and beverage industry, announced today that the Company's President and CEO, Kent Snyder, and its Chief Scientific Officer and Executive Vice President, Mark Zoller, Ph.D., will present a corporate overview on Wednesday, September 12, during the Citigroup Healthy Lifestyles Seminar 2007. The seminar, which is not being webcast, is taking place at the CitiCorp Center in New York City.

The Healthy Lifestyles Seminar is hosted by Citigroup Investment Research and features senior management teams from leading weight loss, natural/organic food, and nutritional supplement companies. Senomyx's presentation will provide a summary of the Company's pipeline of novel flavors, flavor enhancers and taste modulators, which include flavor ingredients intended to reduce added sugar and salt in foods and beverages.

About Senomyx, Inc. (

Senomyx is a leading company using proprietary taste receptor-based assays, screening technologies and optimization chemistry to discover and develop novel flavors, flavor enhancers and taste modulators for the packaged food and beverage industry. The Company is focusing on the development of these flavor ingredients in the savory, sweet, salt and bitter areas. Senomyx has entered into product discovery and development collaborations with seven of the world's leading packaged food and beverage companies: Ajinomoto Co., Inc., Cadbury Schweppes, Campbell Soup Company, The Coca-Cola Company, Kraft Foods Global, Inc., Nestlé SA, and Solae, LLC. Nestlé is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit

Contact Information

  • Contact:
    Gwen Rosenberg
    Senomyx, Inc.
    Vice President, Investor Relations & Corporate Communications
    Email Contact